Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Chembio Diagnostic Systems, Inc.

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Chembio’s focus is on developing, manufacturing and marketing tests for the rapid, simple and cost-effective detection of HIV, Tuberculosis (human and veterinary), and certain other Neglected Diseases. Chembio has a proven commitment toward ensuring sustainable supplies of high quality rapid tests to those who need them by using innovative, socially responsible strategies. Chembio Diagnostic Systems, Inc. operates a cGMP/QS (Good Manufacturing Facility/Quality Systems) manufacturing facility that is registered with the US FDA (Food and Drug Administration). The facility includes dedicated cGMP process manufacturing, Quality Control and R&D laboratories. The company manufacturers class II and class III in vitro diagnostic devices. Chembio ’s HIV assays have been incorporated into the World Health Organization (WHO) Bulk Procurement Scheme and the USAID blanket Waiver List which allows them to be procured with US government funds. In 2006, Former President Bill Clinton announced that his foundation’s HIV/AIDS Initiative negotiated new pricing agreements to lower the prices of HIV diagnostics and two antiretrovirals (ARVs). These products and pricing include Chembio’s STAT-PAK™ HIV 1 / 2 Dipstick. The Foundation’s Procurement Consortium currently includes 50 developing countries around the world.


Contact Details:
3661 Horseblock Road
Medford
New York
11763
United States of America
Tel:1 631 924 1135
Fax:1 631 924 6033
Email:info@chembio.com
WWW:

www.chembio.com/




Loading...

Press Releases on Chembio Diagnostic Systems, Inc.:

BioPortfolio Logo
Reportlinker Adds Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads 5th November, 2009 Reportlinker
NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads

BioNews Results for Chembio Diagnostic Systems, Inc.:

Medical Test Manufacturer Donates 4,500 HIV Test Kits for The World AIDS Day 2009 Testing Millions Global Campaign
Newswise:  Nov 13 2009 8:15PM Matching: chembio diagnostic systems inc

Chembio Diagnostic Systems, Inc. Clinical Trials:

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

Chembio Diagnostic Systems, Inc. Patents:

US Patent No.Title
7569397 Immunoassay devices and use thereof
7387890 Immunoassay devices and use thereof
7192721 Universal rapid test and method for detection of tuberculosis in multiple host species
7189522 Dual path immunoassay device

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 341 times since April 2007, the link to the organisation's website has been followed 49 times

Search for more companies in Medford

Search for more companies in New York



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Chembio Diagnostic Systems, Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.